eloxatin concentrate for soln for inf 5mg/ml (20ml vial)
sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
eloxatin concentrate for soln for inf 5mg/ml (40ml vial)
sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
oxaliplatin ebewe - (100mg vial) pdr for soln for infusion 5mg/ml
1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - oxaliplatin - powder for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
oxaliplatin ebewe - (150mg vial) pdr for soln for infusion 5mg/ml
1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - oxaliplatin - powder for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
oxaliplatin mylan 5mg/ml concentrate for solution for infusion
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
methotrexate mylan solution for inj/inf 25mg/ml (2ml vial)
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg/ml - antineoplastic agents
cisplatin 1 mg/ml concentrate for solution for infusion
pfizer healthcare ireland - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin
cisplatin 1mg/ml concentrate for solution for infusion
accord healthcare ireland ltd. - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin
cisplatin 1 mg/ml concentrate for solution for infusion
fresenius kabi deutschland gmbh - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin
cisplatin intas cisplatin 100 mg/100 ml concentrated injection vial
accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - cisplatin intas may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck